223 related articles for article (PubMed ID: 22014627)
1. Pelvic exenteration with curative intent for recurrent uterine malignancies.
Khoury-Collado F; Einstein MH; Bochner BH; Alektiar KM; Sonoda Y; Abu-Rustum NR; Brown CL; Gardner GJ; Barakat RR; Chi DS
Gynecol Oncol; 2012 Jan; 124(1):42-7. PubMed ID: 22014627
[TBL] [Abstract][Full Text] [Related]
2. Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery.
Andikyan V; Khoury-Collado F; Sonoda Y; Gerst SR; Alektiar KM; Sandhu JS; Bochner BH; Barakat RR; Boland PJ; Chi DS
Gynecol Oncol; 2012 May; 125(2):404-8. PubMed ID: 22285844
[TBL] [Abstract][Full Text] [Related]
3. Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome.
Andikyan V; Khoury-Collado F; Gerst SR; Talukdar S; Bochner BH; Sandhu JS; Abu-Rustum N; Sonoda Y; Barakat RR; Chi DS
Gynecol Oncol; 2012 Sep; 126(3):346-50. PubMed ID: 22555107
[TBL] [Abstract][Full Text] [Related]
4. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
5. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer.
Schmidt AM; Imesch P; Fink D; Egger H
Gynecol Oncol; 2012 Jun; 125(3):604-9. PubMed ID: 22406639
[TBL] [Abstract][Full Text] [Related]
6. Pelvic exenteration for primary and recurrent gynaecological malignancies.
de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
[TBL] [Abstract][Full Text] [Related]
7. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
[TBL] [Abstract][Full Text] [Related]
8. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration.
Morris M; Alvarez RD; Kinney WK; Wilson TO
Gynecol Oncol; 1996 Feb; 60(2):288-91. PubMed ID: 8631553
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in pelvic exenteration for gynecological malignancies.
Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
[TBL] [Abstract][Full Text] [Related]
10. Pelvic exenteration for recurrent endometrial cancer.
Barakat RR; Goldman NA; Patel DA; Venkatraman ES; Curtin JP
Gynecol Oncol; 1999 Oct; 75(1):99-102. PubMed ID: 10502433
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.
Fotopoulou C; Neumann U; Kraetschell R; Schefold JC; Weidemann H; Lichtenegger W; Sehouli J
J Surg Oncol; 2010 May; 101(6):507-12. PubMed ID: 20401918
[TBL] [Abstract][Full Text] [Related]
12. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
[TBL] [Abstract][Full Text] [Related]
13. Pelvic exenteration: long-term oncological results in a series of 106 patients.
De Wever I
Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128
[TBL] [Abstract][Full Text] [Related]
14. Pelvic exenteration for adenocarcinoma of the uterine cervix.
Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT
Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894
[TBL] [Abstract][Full Text] [Related]
15. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
16. Ileal orthotopic neobladder after pelvic exenteration for cervical cancer.
Chiva LM; Lapuente F; Núñez C; Ramírez PT
Gynecol Oncol; 2009 Apr; 113(1):47-51. PubMed ID: 19176235
[TBL] [Abstract][Full Text] [Related]
17. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
[TBL] [Abstract][Full Text] [Related]
18. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer.
Kamat AM; Huang SF; Bermejo CE; Rosser CJ; Pettaway CA; Pisters PW; Guitreau D; Pisters LL
J Urol; 2003 Nov; 170(5):1868-71. PubMed ID: 14532795
[TBL] [Abstract][Full Text] [Related]
19. Surgical resection of recurrent endometrial carcinoma.
Awtrey CS; Cadungog MG; Leitao MM; Alektiar KM; Aghajanian C; Hummer AJ; Barakat RR; Chi DS
Gynecol Oncol; 2006 Sep; 102(3):480-8. PubMed ID: 16490236
[TBL] [Abstract][Full Text] [Related]
20. [Robot-assisted laparoscopy in the management of recurrent pelvic cancer].
Jauffret C; Lambaudie E; Bannier M; Buttarelli M; Houvenaeghel G
Gynecol Obstet Fertil; 2011 Dec; 39(12):674-80. PubMed ID: 21871833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
